Cargando…
Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified
Proton pump inhibitors (PPIs) are common medications within the practice of gastroenterology. These drugs, which act through the irreversible inhibition of the hydrogen/potassium pump (H+/K+-ATPase pump) in the gastric parietal cells, are used in the treatment of several acid-related disorders. PPIs...
Autores principales: | Bruno, Giovanni, Zaccari, Piera, Rocco, Giulia, Scalese, Giulia, Panetta, Cristina, Porowska, Barbara, Pontone, Stefano, Severi, Carola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580352/ https://www.ncbi.nlm.nih.gov/pubmed/31235994 http://dx.doi.org/10.3748/wjg.v25.i22.2706 |
Ejemplares similares
-
Helicobacter pylori Infection and Gastric Dysbiosis: Can Probiotics Administration Be Useful to Treat This Condition?
por: Bruno, Giovanni, et al.
Publicado: (2018) -
Microbiota Alterations in Precancerous Colon Lesions: A Systematic Review
por: Aprile, Francesca, et al.
Publicado: (2021) -
The Potential Role of Hypochlorhydria in the Development of Duodenal Dysbiosis: A Preliminary Report
por: Filardo, Simone, et al.
Publicado: (2022) -
Levothyroxine treatment and gastric juice pH in humans: the proof of concept
por: Virili, Camilla, et al.
Publicado: (2022) -
Lactobacillus rhamnosus GG supplementation on eradication rate and dyspepsia in Helicobacter pylori infection treated with three-in-one bismuth quadruple therapy
por: Marinelli, Paride, et al.
Publicado: (2022)